Goldman Sachs Maintain Buy Raing on MHS

Analysts at Goldman Sachs reiterated their Buy rating on shares of Medco Health Solutions (MHS), stating that the sell-off in shares was "overdone". Goldman Sachs will also keep the $76 price target, as they expect "a strong second half running into 2011...more aggressive share buyback assumptions in 2010 and 2011." Medco Health Solutions, a healthcare company, provides clinically driven pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals in the United States and internationally.